Beijing GenomePrecision Technology Co., Ltd.
PrivateLast Round
Series C
Apr 19, 2021
Total Funding Raised
$20.17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Beijing GenomePrecision Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series C round in April 2021.
Beijing GenomePrecision Technology Co., Ltd. is a biotechnology company that develops and manufactures molecular diagnostic products for precision medicine, focusing on hematologic oncology, transplantation, and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing GenomePrecision Technology Co., Ltd. Comparables
Compare Beijing GenomePrecision Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Annoroad Gene Technology | 88% | |
| Beijing Geneplus Technology | 86% | |
| Berry Genomics Co., Ltd. | 83% |
For institutional investors. Book with your work email.
Beijing GenomePrecision Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 19, 2021 | ||||
| Series B | Feb 18, 2019 | ||||
| Series A | Jun 6, 2017 |
For institutional investors. Book with your work email.
Beijing GenomePrecision Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series C |
| YuanBio Venture Capital | Series A |
| Zhejiang Jiuren Capital Management Co., Ltd. | Series B |
| 华创资本 | Series B |
| Guiyang City Venture Capital Co., Ltd. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 4076% MoM, from 29 to 1.2K.
- Apr 19, 2021
$5.37M round with Oriental Fortune Capital and Guiyang City Venture Capital.
For institutional investors. Book with your work email.
Beijing GenomePrecision Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beijing GenomePrecision Technology Co., Ltd.'s valuation, stock price, and market status.
Is Beijing GenomePrecision Technology Co., Ltd. a public or private company?
Beijing GenomePrecision Technology Co., Ltd. is a private company.
What is the current stock price of Beijing GenomePrecision Technology Co., Ltd.?
Beijing GenomePrecision Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Beijing GenomePrecision Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beijing GenomePrecision Technology Co., Ltd. worth (valuation)?
Valuation information for Beijing GenomePrecision Technology Co., Ltd. is not publicly available.
Can I buy Beijing GenomePrecision Technology Co., Ltd. stock?
Beijing GenomePrecision Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beijing GenomePrecision Technology Co., Ltd.'s last funding round?
Beijing GenomePrecision Technology Co., Ltd.'s most recent funding round was Series C on April 19, 2021.
Who are the main investors in Beijing GenomePrecision Technology Co., Ltd.?
Key investors in Beijing GenomePrecision Technology Co., Ltd. include Oriental Fortune Capital, YuanBio Venture Capital, Zhejiang Jiuren Capital Management Co., Ltd., 华创资本, Guiyang City Venture Capital Co., Ltd..
Will Beijing GenomePrecision Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing GenomePrecision Technology Co., Ltd..
How can I track Beijing GenomePrecision Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Beijing GenomePrecision Technology Co., Ltd.'s shares on secondary markets.